| Primary |
| Hypercholesterolaemia |
27.7% |
| Cardiac Disorder |
17.6% |
| Hypertension |
6.7% |
| Dyslipidaemia |
5.9% |
| Infarction |
5.0% |
| Hyperlipidaemia |
4.2% |
| Cardiovascular Disorder |
3.4% |
| Coronary Angioplasty |
3.4% |
| Acute Myocardial Infarction |
2.5% |
| Atrial Fibrillation |
2.5% |
| Coronary Artery Disease |
2.5% |
| Essential Hypertension |
2.5% |
| Intentional Overdose |
2.5% |
| Prophylaxis Against Gastrointestinal Ulcer |
2.5% |
| Tachycardia |
2.5% |
| Angioplasty |
1.7% |
| Arteriosclerosis |
1.7% |
| Arteriosclerosis Obliterans |
1.7% |
| Asthma |
1.7% |
| Benign Prostatic Hyperplasia |
1.7% |
|
| Myalgia |
10.5% |
| Rhabdomyolysis |
10.5% |
| Dermatitis Exfoliative Generalised |
7.0% |
| Liver Disorder |
7.0% |
| Respiratory Failure |
7.0% |
| Jaundice |
5.3% |
| Vasculitis |
5.3% |
| Weight Decreased |
5.3% |
| Blood Pressure Increased |
3.5% |
| Dermatitis |
3.5% |
| Face Oedema |
3.5% |
| Interstitial Lung Disease |
3.5% |
| Lip Oedema |
3.5% |
| Motor Neurone Disease |
3.5% |
| Pruritus |
3.5% |
| Rash Generalised |
3.5% |
| Shock |
3.5% |
| Tachycardia |
3.5% |
| Throat Irritation |
3.5% |
| Vomiting |
3.5% |
|
| Secondary |
| Product Used For Unknown Indication |
10.9% |
| Dyslipidaemia |
10.0% |
| Self Injurious Behaviour |
10.0% |
| Hypercholesterolaemia |
8.2% |
| Asthma |
5.5% |
| Benign Prostatic Hyperplasia |
5.5% |
| Cardiac Disorder |
5.5% |
| Coronary Angioplasty |
5.5% |
| Drug Use For Unknown Indication |
4.5% |
| Myocardial Infarction |
4.5% |
| Essential Hypertension |
3.6% |
| Major Depression |
3.6% |
| Multiple Sclerosis |
3.6% |
| Cardiovascular Disorder |
2.7% |
| Diabetes Mellitus |
2.7% |
| Emphysema |
2.7% |
| Gastritis |
2.7% |
| Influenza |
2.7% |
| Ischaemic Cardiomyopathy |
2.7% |
| Multiple Drug Overdose Intentional |
2.7% |
|
| Rhabdomyolysis |
17.1% |
| Rash Erythematous |
11.4% |
| Dermatitis Exfoliative Generalised |
5.7% |
| Hepatitis Acute |
5.7% |
| Pruritus |
5.7% |
| Rash Generalised |
5.7% |
| Syncope |
5.7% |
| Transaminases Increased |
5.7% |
| White Blood Cell Disorder |
5.7% |
| Chest Pain |
2.9% |
| Impetigo |
2.9% |
| Liver Disorder |
2.9% |
| Myalgia |
2.9% |
| Pneumonia |
2.9% |
| Self Injurious Behaviour |
2.9% |
| Sluggishness |
2.9% |
| Tetany |
2.9% |
| Thrombocytopenia |
2.9% |
| Vertigo |
2.9% |
| White Blood Cell Count Decreased |
2.9% |
|
| Concomitant |
| Product Used For Unknown Indication |
29.6% |
| Drug Use For Unknown Indication |
18.7% |
| Hypertension |
12.9% |
| Diabetes Mellitus |
4.2% |
| Prophylaxis |
4.0% |
| Acute Myocardial Infarction |
3.5% |
| Cardiomyopathy |
3.0% |
| Hypercholesterolaemia |
3.0% |
| Type 2 Diabetes Mellitus |
2.9% |
| Atrial Fibrillation |
2.8% |
| Non-small Cell Lung Cancer |
2.6% |
| Thrombosis Prophylaxis |
2.3% |
| Diffuse Large B-cell Lymphoma |
2.2% |
| Myocardial Ischaemia |
1.9% |
| Dyslipidaemia |
1.4% |
| Cough |
1.1% |
| Non-hodgkin's Lymphoma |
1.1% |
| Angioplasty |
1.0% |
| Essential Hypertension |
1.0% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.0% |
|
| Vomiting |
11.6% |
| Presyncope |
10.1% |
| Renal Failure Acute |
7.8% |
| Sopor |
7.8% |
| Transient Ischaemic Attack |
7.8% |
| Thrombocytopenia |
7.0% |
| Syncope |
5.4% |
| Epistaxis |
3.9% |
| Erythema |
3.9% |
| Respiratory Failure |
3.9% |
| Vertigo |
3.9% |
| Acute Coronary Syndrome |
3.1% |
| Hypocoagulable State |
3.1% |
| Hypoglycaemia |
3.1% |
| Melaena |
3.1% |
| Pulmonary Oedema |
3.1% |
| Rib Fracture |
3.1% |
| Sepsis |
3.1% |
| Urticaria |
3.1% |
| Acute Myocardial Infarction |
2.3% |
|
